FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...
The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.
Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN ...
The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...
The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...
Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN FRANCISCO, Calif, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, ...
1don MSN
A CT hospital is expanding a program that is saving lives. Here’s how it works, why it was adopted
Use of whole blood products to save egregiously injured U.S. military combatants became a practice during wars in Iraq and ...
MS NOW on MSNOpinion
Trump quadrupling up on aspirin is a metaphor for his presidency
Trump casually dismisses evidence-based recommendations as he attacks panels that makes such recommendations for the American ...
The American Red Cross urges donors to make an appointment to give blood or platelets now to keep the blood supply as strong ...
Data is from comprehensive review of hospital charges and all-payer claims over five years - - Preventable complications such as amputation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback